View in EDS

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.

Saved in:
Bibliographic Details
Title: A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
Authors: Harvey VJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland. Electronic address: vernonh@adhb.govt.nz., Sharples KJ; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland; Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin., Isaacs RJ; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North., Jameson MB; Waikato Regional Cancer Centre, Waikato Hospital, Hamilton., Jeffery GM; Oncology Service, Christchurch Hospital, Christchurch., McLaren BR; Southern Blood and Cancer Service, Dunedin Hospital, Dunedin., Pollard S; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Riley GA; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Simpson AB; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., Hinder VA; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Scott JN; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Dzhelali MV; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., Findlay MP; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Jul; Vol. 24 (7), pp. 1828-1834. Date of Electronic Publication: 2013 Mar 04.
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1093/annonc/mdt065